Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 14, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Second Quarter 2020 Financial Results on Tuesday August 4, 2020

TEMPLE CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2020...
June 16, 2020 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19

TEMPLE CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing solutions, today...
May 18, 2020 06:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19

TEMPLE CITY, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing solutions, today...
May 04, 2020 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports First Quarter 2020 Financial Results

First Quarter 2020 Results: Revenue totals $7.8 million, growing 44% year over yearBillable tests delivered total 13,163, growing 75% year over yearGross Margin improves approximately 3 percentage...
April 09, 2020 08:01 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce First Quarter 2020 Financial Results on Monday May 4, 2020

TEMPLE CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2020...
April 09, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Provides Update on Testing for COVID-19

TEMPLE CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
March 17, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)

TEMPLE CITY, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
March 10, 2020 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results

Fourth Quarter 2019 Results: Revenue totals $8.4 million, growing 48% year over yearBillable tests delivered total 13,977, growing 118% year over yearGross Margin improves more than 5 percentage...
March 10, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Announces Promotion of Brandon Perthuis to Chief Commercial Officer

TEMPLE CITY, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
February 20, 2020 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020

TEMPLE CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full...